Sale of PDL’s lucrative royalty stream or even the company itself is not off the table as reorganization unfolds.
Join thousands of industry professionals who rely on Pink Sheet for daily insights
Already a subscriber?
Legal experts warn, however, that new Mexican procurement rules are discriminatory and could be challenged in the courts.
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the EU, and updates on EU marketing authorization changes recommended by the CHMP.
The Trump Administration’s rhetoric and policy approaches illustrate the confusion that often arises between efforts to cut drug prices and cutting spending.
